SEC Form 4 · accession 0001562180-16-001270

Dermira, Inc. · DERM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CEO & Chairman of the Board · Director

Period of report

Jan 4, 2016

Accepted (ET)

Jan 6, 2016 · 9:27 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001557883

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2,F3	Jan 4, 2016	S	10,492	$33.13	D	247,688	I	By the Wiggans Living Trust dated 5/14/02
Common Stock^F4,F3	Jan 4, 2016	S	508	$33.95	D	247,180	I	By the Wiggans Living Trust dated 5/14/02
Common Stock^F5	holding	—	—		—	8,620	I	By the Amanda Wiggans Irrevocable Gifting Trust dated 2/24/11
Common Stock^F5	holding	—	—		—	8,620	I	By the Elizabeth Wiggans Irrevocable Gifting Trust dated 2/24/11

No Table II lines on this filing.

F1These trades were made pursuant to a Rule 10b5-1 trading plan.
F2This transaction was executed in multiple trades at prices ranging from $32.61 to $33.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3The Reporting Person is a Co-Trustee.
F4This transaction was executed in multiple trades at prices ranging from $33.64 to $34.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5The Reporting Person has no voting or dispositive power over the shares held by the trust.